Piperacillin, Tazobactam (X-GEN Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Piperacillin, Tazobactam drug offered from X-GEN Pharmaceuticals, Inc.. This Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | X-GEN Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Piperacillin, Tazobactam |
SUBSTANCE NAME: | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
START MARKETING DATE: | 2017-02-14 |
END MARKETING DATE: | 2017-11-30 |
Piperacillin, Tazobactam HUMAN PRESCRIPTION DRUG Details:
Item Description | Piperacillin, Tazobactam from X-GEN Pharmaceuticals, Inc. |
LABELER NAME: | X-GEN Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; .375(g/20mL; g/20mL) |
START MARKETING DATE: | 2017-02-14 |
END MARKETING DATE: | 2017-11-30 |
PRODUCT ID: | 39822-9993_d358a8fa-0593-466b-b8d8-43a4ef110ae6 |
PRODUCT NDC: | 39822-9993 |
APPLICATION NUMBER: | |
Other PIPERACILLIN SODIUM; TAZOBACTAM SODIUM Pharmaceutical Manufacturers / Labelers: